FDA weighs new COVID antibody drug that could be 'holy grail' for immunocompromised: AZD7442 showed 77% efficacy, AstraZeneca said

FDA weighs new COVID antibody drug that could be 'holy grail' for immunocompromised: AZD7442 showed 77% efficacy, AstraZeneca said submitted by /u/shallah
[link] [comments]
by at
Tags

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)